China’s Food and Drug Administration has started implementing key reforms that are likely to be a game changer for pharma companies eyeing the Chinese market. The presentation below highlights the key reforms: Key Takeaways: Leveling of Phase 1 playing field: Pharma companies can run a phase 1 trial […]